These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 9641651)

  • 1. Enhanced levels of C-X-C chemokine, human GROalpha, in Helicobacter pylori-associated gastric disease.
    Suzuki H; Mori M; Sakaguchi AA; Suzuki M; Miura S; Ishii H
    J Gastroenterol Hepatol; 1998 May; 13(5):516-20. PubMed ID: 9641651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of neutrophil infiltration in the corpus after failure of Helicobacter pylori eradication.
    Suzuki M; Mori M; Miyayama A; Iwai N; Tsunematsu N; Oonuki M; Suzuki H; Hibi T; Ishii H
    J Clin Gastroenterol; 1997; 25 Suppl 1():S222-8. PubMed ID: 9479652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokines in the gastric mucosa in Helicobacter pylori infection.
    Yamaoka Y; Kita M; Kodama T; Sawai N; Tanahashi T; Kashima K; Imanishi J
    Gut; 1998 May; 42(5):609-17. PubMed ID: 9659152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal chemokine activity in Helicobacter pylori infection.
    Kusugami K; Ando T; Ohsuga M; Imada A; Shinoda M; Konagaya T; Ina K; Kasuga N; Fukatsu A; Ichiyama S; Nada T; Ohta M
    J Clin Gastroenterol; 1997; 25 Suppl 1():S203-10. PubMed ID: 9479649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional differences on production of chemokines in gastric mucosa between Helicobacter pylori-positive duodenal ulcer and gastric ulcer.
    Sato Y; Sugimura K; Mochizuki T; Honma T; Suriki H; Tashiro K; Ishizuka K; Narisawa R; Ichida T; Van Thiel DH; Asakura H
    Dig Dis Sci; 1999 Dec; 44(12):2390-6. PubMed ID: 10630487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of lactoferrin levels in gastric mucosa with Helicobacter pylori infection and with the degree of gastric inflammation.
    Nakao K; Imoto I; Ikemura N; Shibata T; Takaji S; Taguchi Y; Misaki M; Yamauchi K; Yamazaki N
    Am J Gastroenterol; 1997 Jun; 92(6):1005-11. PubMed ID: 9177520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for the role of gastric mucosa at the secretion of soluble triggering receptor expressed on myeloid cells (strem-1) in peptic ulcer disease.
    Koussoulas V; Vassiliou S; Spyridaki E; Demonakou M; Vaki I; Barbatzas C; Giamarellou H; Giamarellos-Bourboulis EJ
    World J Gastroenterol; 2007 Sep; 13(34):4610-4. PubMed ID: 17729416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normalization of phospholipids concentration of the gastric mucosa was observed in patients with peptic ulcer after eradication of Helicobacter pylori.
    Ishibashi S; Iwakiri R; Shimoda R; Ootani H; Kawasaki S; Tadano J; Kikkawa A; Ootani A; Oda K; Fujise T; Yoshida T; Tsunada S; Sakata H; Fujimoto K
    Helicobacter; 2002 Aug; 7(4):245-9. PubMed ID: 12165032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of omeprazole and lansoprazole in short-term triple therapy for Helicobacter pylori infection.
    Spinzi GC; Bierti L; Bortoli A; Colombo E; Fertitta AM; Lanzi GL; Venturelli R; Minoli G
    Aliment Pharmacol Ther; 1998 May; 12(5):433-8. PubMed ID: 9663722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Helicobacter pylori infection on gastric juice pH.
    Furuta T; Baba S; Takashima M; Futami H; Arai H; Kajimura M; Hanai H; Kaneko E
    Scand J Gastroenterol; 1998 Apr; 33(4):357-63. PubMed ID: 9605256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of CYP2C19 polymorphism and Helicobacter pylori genotype determined from gastric tissue samples on response to triple therapy for H pylori infection.
    Furuta T; Sagehashi Y; Shirai N; Sugimoto M; Nakamura A; Kodaira M; Kenmotsu K; Nagano M; Egashira T; Ueda K; Yoneyama M; Ohashi K; Ishizaki T; Hishida A
    Clin Gastroenterol Hepatol; 2005 Jun; 3(6):564-73. PubMed ID: 15952098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing Helicobacter pylori eradication with 2 week combination therapy of lansoprazole and amoxycillin: intragastric distribution of colonization and gastric mucosal atrophy.
    Saita H; Murakami M; Takahashi Y; Sou Y; Kaitani K; Nishio K; Kita T
    J Gastroenterol Hepatol; 1998 Jul; 13(7):725-31. PubMed ID: 9715425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. gammadelta T cells increase with gastric mucosal interleukin (IL)-7, IL-1beta, and Helicobacter pylori urease specific immunoglobulin levels via CCR2 upregulation in Helicobacter pylori gastritis.
    Futagami S; Hiratsuka T; Suzuki K; Kusunoki M; Wada K; Miyake K; Ohashi K; Shimizu M; Takahashi H; Gudis K; Kato S; Tsukui T; Sakamoto C
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):32-40. PubMed ID: 16706809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does eradication of Helicobacter pylori reduce the risk of carcinogenesis in the residual stomach after gastrectomy for early gastric cancer? Comparison of mucosal lesions in the residual stomach before and after Helicobacter pylori eradication.
    Hamaguchi K; Ogawa K; Katsube T; Konno S; Aiba M
    Langenbecks Arch Surg; 2004 Apr; 389(2):83-91. PubMed ID: 14767774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of smoking and alcohol on gastric chemokine mRNA expression in patients with Helicobacter pylori infection.
    Shimoyama T; Everett SM; Fukuda S; Axon AT; Dixon MF; Crabtree JE
    J Clin Pathol; 2001 Apr; 54(4):332-4. PubMed ID: 11304855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
    Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E
    Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
    Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
    Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant increase in eradication rates of Helicobacter pylori infection with two consecutive dual therapies (omeprazole and amoxycillin or omeprazole and clarithromycin). A randomized study in 450 Spanish patients.
    Moreno JA; Pajares JM; Santander C; Carpintero P; Hermida C; Lara S; García Grávalos R
    J Gastroenterol; 1996 Nov; 31 Suppl 9():48-52. PubMed ID: 8959519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amount of Helicobacter pylori in gastric mucus during anti-H. pylori treatment.
    Furuta T; Takashima M; Futami H; Arai H; Hanai H; Kaneko E
    J Gastroenterol Hepatol; 1998 May; 13(5):511-5. PubMed ID: 9641650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-dependent eradication of Helicobacter pylori with dual therapy.
    Treiber G; Ammon S; Klotz U
    Aliment Pharmacol Ther; 1997 Aug; 11(4):711-8. PubMed ID: 9305480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.